Tonix Pharmaceuticals Holding Corp.

Go to Tonix Pharmaceuticals Holding Corp. Website

$45.37

0.73 (1.64%)
Live
Previous Close

$44.64

Day Range

$0 - $0

Previous Day Range

$40.43 - $46.23

Market Cap

$287.0 million USD

Day Vol.

0

Previous Day Vol.

2.2 million

Currency

USD

Primary Exchange

Nasdaq

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervou...


Community
  • 0 posts discussing
0

Watchers

1

Visitors


Recent News

Tonix Pharmaceuticals has appointed James "Jim" Hunter, a commercial industry veteran, to its Board of Directors. Hunter previously served as Executive Vice President of Commercial Operations at Tonix and will provide valuable expertise as the company prepares for the potential launch of TNX-102 SL for fibromyalgia.

Related tickers: TNXP.

Read Full Article

Tonix Pharmaceuticals has dosed the first patient in a Phase 2 trial evaluating TNX-102 SL for reducing acute stress reaction and acute stress disorder. The trial is sponsored by the University of North Carolina and supported by a grant from the U.S. Department of Defense. Topline results are expected in the second half of 2026.

Related tickers: TNXP.

Read Full Article
Trending Tickers

Please sign in to view